We are live on ! Find out more
Nuveen

Nuveen Portfolio holdings

AUM $419B
1-Year Est. Return 43.02%
This Fund
S&P 500
This Quarter Est. Return
+26.22%
1 Year Est. Return
+43.02%
3 Year Est. Return
+139.43%
5 Year Est. Return
+185.66%
10 Year Est. Return
+615.13%
AUM
$246B
AUM Growth
+$40.4B
Cap. Flow
-$4.05B
Cap. Flow %
-1.65%
Top 10 Hldgs %
22.52%
Holding
3,466
New
266
Increased
1,402
Reduced
1,481
Closed
200

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$613M
2
MTCH icon
Match Group
MTCH
+$518M
3
META icon
Meta Platforms (Facebook)
META
+$508M
4
RTX icon
RTX Corp
RTX
+$456M
5
LLY icon
Eli Lilly
LLY
+$364M

Top Sells

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$828M
2
MSFT icon
Microsoft
MSFT
+$510M
3
GILD icon
Gilead Sciences
GILD
+$465M
4
MRK icon
Merck
MRK
+$376M
5
WMT icon
Walmart Inc
WMT
+$369M

Sector Composition

Rank Sector Weight
1 Technology 23.85%
2 Healthcare 14.27%
3 Financials 12.45%
4 Consumer Discretionary 12.22%
5 Communication Services 9.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GENC icon
2976
Gencor Industries
GENC
$256M
$398K ﹤0.01%
31,532
+4,310
+16% +$49.9K
PCB icon
2977
PCB Bancorp
PCB
$389M
$398K ﹤0.01%
38,600
+5,482
+17% +$49.7K
ASPS icon
2978
Altisource Portfolio Solutions
ASPS
$62.7M
$396K ﹤0.01%
3,360
-467
-12% -$38.4K
FNWB icon
2979
First Northwest Bancorp
FNWB
$95.6M
$396K ﹤0.01%
31,849
-2,474
-7% -$29.1K
STRO icon
2980
Sutro Biopharma
STRO
$265M
$393K ﹤0.01%
5,074
+1,130
+29% +$108K
CFRX
2981
DELISTED
ContraFect Corporation
CFRX
$392K ﹤0.01%
+768
New +$377K
CRK icon
2982
Comstock Resources
CRK
$3.85B
$391K ﹤0.01%
89,154
+19,394
+28% +$116K
GNLN icon
2983
Greenlane Holdings
GNLN
$2.13M
– –
0
– –
PAVM icon
2984
PAVmed
PAVM
$37.9M
$389K ﹤0.01%
+410
New +$410K
IQI icon
2985
Invesco Quality Municipal Securities
IQI
$473M
$388K ﹤0.01%
32,524
– –
BLE
2986
DELISTED
BlackRock Municipal Income Trust II
BLE
$385K ﹤0.01%
26,189
– –
PBIP
2987
DELISTED
Prudential Bancorp, Inc.
PBIP
$385K ﹤0.01%
32,012
+956
+3% +$11.4K
CKPT
2988
DELISTED
Checkpoint Therapeutics
CKPT
$384K ﹤0.01%
19,378
+9,974
+106% +$182K
RYZ
2989
Ryerson Holding Corp
RYZ
$1.24B
$384K ﹤0.01%
68,130
-139,018
-67% -$688K
OESX icon
2990
Orion Energy Systems
OESX
$125M
$382K ﹤0.01%
+11,040
New +$452K
FLNA
2991
Filana Therapeutics
FLNA
$36.1M
$382K ﹤0.01%
+123,769
New +$561K
ELMD icon
2992
Electromed
ELMD
$233M
$380K ﹤0.01%
+24,716
New +$342K
EOLS icon
2993
Evolus
EOLS
$526M
$379K ﹤0.01%
71,638
-14,845
-17% -$68.4K
VTOL icon
2994
Bristow Group
VTOL
$1.26B
$379K ﹤0.01%
27,205
-16,247
-37% -$174K
RFL icon
2995
Rafael Holdings
RFL
$101M
$374K ﹤0.01%
26,413
-18,203
-41% -$251K
GAIA icon
2996
Gaia
GAIA
$33.1M
$373K ﹤0.01%
44,510
+5,549
+14% +$48.2K
TLPH icon
2997
Talphera
TLPH
$61.2M
$372K ﹤0.01%
15,372
-5,682
-27% -$158K
GDYN icon
2998
Grid Dynamics Holdings
GDYN
$629M
$371K ﹤0.01%
+53,673
New +$440K
EPM icon
2999
Evolution Petroleum
EPM
$141M
$370K ﹤0.01%
132,189
-171,790
-57% -$461K
ESXB
3000
DELISTED
Community Bankers Trust Corporation
ESXB
$369K ﹤0.01%
67,007
-7,533
-10% -$39.3K

Similar funds

Nuveen's Q2 2020 Portfolio in Review

As of Q2 2020, Nuveen held 3,466 positions worth $246B, up 20% from $205B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Nuveen's Q2 2020 filing shows 266 new, 1,402 increased, 1,481 reduced and 200 closed positions. Its largest new stake was Zoom: 841,153 shares worth $213M. The largest sale was Amazon, an estimated $828M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.

  • Nuveen's largest Q2 2020 buy was Zoom: 841,153 shares worth $213M.
  • Nuveen added most to AbbVie in Q2 2020, an estimated $613M increase.
  • Nuveen's biggest Q2 2020 reduction was Amazon, cutting an estimated $828M.
  • Nuveen fully exited Allergan plc in Q2 2020, selling an estimated $212M.
  • Nuveen's ten largest holdings make up 23% of its $246B portfolio in Q2 2020.
  • Nuveen opened 266 new positions and closed 200 in Q2 2020.
  • Nuveen's portfolio value rose 20% quarter-over-quarter to $246B.

Based on Nuveen's 13F filing for Q2 2020, filed 14 Aug 2020.